MetaCap

22nd Century Group Inc. (XXII)

NASDAQ: XXIIHealth Care Medicinal Chemicals and Botanical Products USD

0.3365-0.0614 (-15.43%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

XXII stock chart

Technical analysis

Key statistics

All statistics
EPS (TTM)
$4,528.07
52-week range
0.295 – 20,323.20
Day range
0.2993 – 0.3658
Volume / Avg
1.68M / 1.21M
Beta
—

52-week range

$0.295$20,323.20

XXII stock today

22nd Century Group (XXII) closed at $0.3365 on Nov 20, down 15.43% (-$0.0614), versus the S&P 500's 3.70% decline. At this level, XXII sits near the bottom of its 52-week range of $0.295 to $20,323.20: 100.0% below the high and 14.1% above the low. 22nd Century Group trades at 0.0x its trailing twelve-month earnings per share of $4,528.07.

Summary generated from market data by MetaCap's automated system. Methodology

About 22nd Century Group

Company profile

22nd Century Group, Inc., a tobacco products company, manufactures, distributes, and sells proprietary new reduced nicotine tobacco products in the United States. The company offers reduced nicotine content tobacco and very low nicotine combustible cigarette products. It also provides contract manufacturing services for conventional combustible tobacco products for third-party brands, as well as turnkey contract manufacturing of cigarettes and filtered cigars for other established tobacco brands.

Industry
Medicinal Chemicals and Botanical Products
CEO
Mr. Lawrence D. Firestone
Headquarters
Mocksville, NC
Employees
32

Financial highlights

Full financials

In fiscal 2025, 22nd Century Group generated $17.6 million in revenue, down 27.9% from fiscal 2024, its first annual decline since 2024. 22nd Century Group reported a net loss of $5.1 million, compared with a loss of $15.2 million a year earlier. Gross margin was 42.1% (up from 41.4%) and operating margin -65.8%.

22nd Century Group annual revenue, net income and EPS
Fiscal yearFY 2025FY 2024FY 2023FY 2022FY 2021
Revenue$17.59M$24.38M$32.20M$40.50M$30.95M
Growth-27.87%-24.29%-20.49%+30.87%+10.09%
Net income$-5.05M$-15.16M$-140.78M$-59.80M$-32.61M
EPS (diluted)$-52.87$-45,711.05$-15,925.99$-4.65$-0.21

Earnings

Earnings history
Last reported (Sep/2026)
Nov 16, 2026
EPS actual vs est.
$-227.49 vs —

XXII news

All XXII news

22nd Century Group peers

Health Care sector
XXII peer companies
CompanyPrice% ChgMarket capCompare
IMCCIM Cannabis Corp.0.4999+7.23%$307.30Kvs XXII
MTEXMannatech Incorporated2.56+5.13%$4.94Mvs XXII
NAIINatural Alternatives International Inc.0.876-2.67%$5.48Mvs XXII
BONBon Natural Life Limited Class A1.04-0.50%$8.53Mvs XXII
AKANAkanda Corp.4.23+23.32%$11.16Mvs XXII
BTMDBiote Corp. Class A0.8147-3.56%$26.28Mvs XXII
FTLFFitLife Brands Inc.6.20-7.46%$58.22Mvs XXII
ISPRIspire Technology Inc.1.23-3.15%$71.05Mvs XXII

Indexes, lists and sector

22nd Century Group stock FAQ

What is 22nd Century Group's stock price today?

XXII last traded at $0.3365 as of Nov 20, 4:00 PM EST, down 15.43% on the day. Prices are delayed at least 15 minutes.

Does 22nd Century Group pay a dividend?

No. 22nd Century Group does not currently pay a regular cash dividend.

What is XXII's P/E ratio?

XXII trades at a trailing P/E ratio of 0.00.

Who is 22nd Century Group's CEO?

Mr. Lawrence D. Firestone is the chief executive officer of 22nd Century Group Inc., which has about 32 employees.

Has XXII ever split its stock?

Yes. The most recent XXII stock split was a 1-for-58 split on Nov 5, 2026.

What is the XXII 52-week high?

The 52-week high for XXII is $20,323.20 and the 52-week low is $0.295. The stock is currently 100.0% below its high.

Compare XXII